Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19610 | 26458397 | BMC Med Genet | MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study. | 2015 | Details |
| A19611 | 26457389 | Hepatology | Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study. | 2015 | Details |
| A19612 | 26457022 | World J Gastroenterol | Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. | 2015 | Details |
| A19613 | 26457019 | World J Gastroenterol | Does herbal medicine reduce the risk of hepatocellular carcinoma? | 2015 | Details |
| A19616 | 26456168 | J Gastroenterol | Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. | 2015 | Details |
| A19617 | 26454945 | Wei Sheng Yan Jiu | [Relation between dietary iron intake and nonalcoholic fatty liver disease]. | 2015 | Details |
| A19618 | 26454786 | Dig Liver Dis | Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. | 2015 | Details |
| A19619 | 26454513 | QJM | Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. | 2015 | Details |
| A19621 | 26450572 | BMC Pediatr | A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study. | 2015 | Details |
| A19622 | 26450277 | Br J Nutr | Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH). | 2015 | Details |
| A19623 | 26449892 | Nutr Clin Pract | Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19624 | 26449595 | J Agric Food Chem | Endocrine Disruptor DDE Associated with a High-Fat Diet Enhances the Impairment of Liver Fatty Acid Composition in Rats. | 2015 | Details |
| A19625 | 26449539 | BMC Genomics | The impact of PPARα activation on whole genome gene expression in human precision cut liver slices. | 2015 | Details |
| A19627 | 26448028 | Medicine (Baltimore) | Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis. | 2015 | Details |
| A19628 | 26448014 | Medicine (Baltimore) | Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese. | 2015 | Details |
| A19629 | 26447961 | J Clin Gastroenterol | Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. | 2016 | Details |
| A19631 | 26447642 | J Child Adolesc Psychopharmacol | Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management. | 2015 | Details |
| A19632 | 26447219 | Am J Physiol Renal Physiol | NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity. | 2015 | Details |
| A19633 | 26447006 | JBI Database System Rev Implement Rep | Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol. | 2015 | Details |
| A19635 | 26445592 | Nutr Metab (Lond) | Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1. | 2015 | Details |
| A19636 | 26444696 | Liver Int | Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. | 2015 | Details |
| A19637 | 26444605 | Clin Hemorheol Microcirc | Association of whole blood viscosity with non-alcoholic fatty liver disease. | 2015 | Details |
| A19638 | 26444279 | Clin Exp Pharmacol Physiol | Increased ratio of neutrophil elastase to α1-antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis. | 2016 | Details |
| A19639 | 26442880 | Am J Physiol Endocrinol Metab | Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway. | 2015 | Details |
| A19641 | 26441837 | Front Endocrinol (Lausanne) | Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD. | 2015 | Details |
| A19642 | 26441288 | Aten Primaria | [Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care]. | 2015 | Details |
| A19643 | 26441244 | PLoS One | Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients. | 2015 | Details |
| A19644 | 26441241 | Endocrinology | SHBG-C57BL/ksJ-db/db: A New Mouse Model to Study SHBG Expression and Regulation During Obesity Development. | 2015 | Details |
| A19645 | 26439744 | PLoS One | Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A19646 | 26439042 | Eur Rev Med Pharmacol Sci | Insulin sensitivity indices: fasting versus glucose-stimulated ındices in pediatric non-alcoholic fatty liver disease. | 2015 | Details |
| A19647 | 26438694 | Dis Model Mech | Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats. | 2015 | Details |
| A19648 | 26438057 | Biometals | Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload. | 2015 | Details |
| A19649 | 26438035 | BMC Complement Altern Med | Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity. | 2015 | Details |
| A19650 | 26436447 | Liver Int | Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives. | 2015 | Details |
| A19652 | 26436355 | Ann Hepatol | Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease. | 2016 | Details |
| A19653 | 26436351 | Ann Hepatol | Drug-induced fatty liver disease: An overview of pathogenesis and management. | 2016 | Details |
| A19654 | 26435078 | Metabolism | The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. | 2015 | Details |
| A19655 | 26435020 | Bratisl Lek Listy | Petroselinum crispum extract attenuates hepatic steatosis in rats fed with fructose enriched diet. | 2015 | Details |
| A19656 | 26433207 | Diabet Med | Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. | 2015 | Details |
| A19657 | 26433072 | Mol Cell Endocrinol | Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. | 2015 | Details |
| A19658 | 26432021 | Trends Mol Med | Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19659 | 26431876 | Biochem Biophys Res Commun | Hepatic scavenger receptor BI is associated with type 2 diabetes but unrelated to human and murine non-alcoholic fatty liver disease. | 2015 | Details |
| A19660 | 26430826 | J Am Coll Nutr | Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial. | 2015 | Details |
| A19661 | 26430807 | J Gastroenterol Hepatol | Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model. | 2016 | Details |
| A19662 | 26429665 | Nutrition | ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease. | 2015 | Details |
| A19663 | 26428356 | Chem Biol Interact | Chemical characteristics for optimizing CYP2E1 inhibition. | 2015 | Details |
| A19664 | 26428254 | Obes Surg | Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base. | 2016 | Details |
| A19667 | 26426796 | Clin Transl Gastroenterol | Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis. | 2015 | Details |
| A19668 | 26426614 | Medicine (Baltimore) | Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article. | 2015 | Details |
| A19669 | 26425466 | Indian J Endocrinol Metab | Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. | 2015 | Details |
| A19670 | 26424731 | Clin Sci (Lond) | Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19671 | 26423681 | Biochem Genet | Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes. | 2015 | Details |
| A19672 | 26423094 | J Endocrinol | Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. | 2015 | Details |
| A19673 | 26420354 | Eur J Pharmacol | Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition. | 2015 | Details |
| A19674 | 26420011 | Environ Health | Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study. | 2015 | Details |
| A19675 | 26419929 | Mol Cell Endocrinol | C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress. | 2015 | Details |
| A19676 | 26419119 | Expert Opin Ther Targets | Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. | 2015 | Details |
| A19677 | 30538833 | Curr Health Sci J | Genetic Factors Involved in the Development and Progression of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19678 | 28294798 | Kardiologiia | [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. | 2015 | Details |
| A19679 | 26418083 | PLoS One | Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy. | 2015 | Details |
| A19681 | 26416722 | Arch Biochem Biophys | MicroRNAs in obesity-associated disorders. | 2015 | Details |
| A19682 | 26415102 | J Pathol | Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers. | 2016 | Details |
| A19683 | 26414963 | J Clin Endocrinol Metab | Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men. | 2015 | Details |
| A19684 | 26412465 | Curr Pharm Des | Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome. | 2015 | Details |
| A19685 | 26411937 | Nihon Eiseigaku Zasshi | [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis]. | 2015 | Details |
| A19686 | 26410018 | Hum Pathol | Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study. | 2015 | Details |
| A19687 | 26409295 | Metabolism | Genetics of nonalcoholic fatty liver disease. | 2015 | Details |
| A19689 | 26408952 | Prostaglandins Other Lipid Mediat | Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study. | 2015 | Details |
| A19690 | 26408054 | Contemp Clin Trials | The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study. | 2015 | Details |
| A19691 | 26407715 | Diabetologia | Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2015 | Details |
| A19692 | 26407654 | Eur J Pharmacol | Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients. | 2015 | Details |
| A19693 | 26406351 | J Dig Dis | Nonalcoholic fatty liver disease - current status and future directions. | 2015 | Details |
| A19694 | 26406278 | Hepatology | Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study. | 2015 | Details |
| A19695 | 26406121 | Hepatology | Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. | 2015 | Details |
| A19696 | 26405765 | PLoS One | Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil. | 2015 | Details |
| A19698 | 26405708 | J Gastrointestin Liver Dis | Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity? | 2015 | Details |
| A19699 | 26405701 | J Gastrointestin Liver Dis | The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19700 | 26405687 | Cell Mol Gastroenterol Hepatol | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability. | 2015 | Details |
| A19701 | 26405614 | Cardiovasc Endocrinol | Relevance of low testosterone to non-alcoholic fatty liver disease. | 2015 | Details |
| A19702 | 26404765 | Hepatology | Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. | 2015 | Details |
| A19703 | 26404254 | Int J Mol Sci | Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice. | 2015 | Details |
| A19704 | 26404062 | Diabetologia | A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. | 2015 | Details |
| A19705 | 26403427 | Dig Dis Sci | Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model. | 2015 | Details |
| A19706 | 26402655 | Transpl Int | Liver transplantation for nonalcoholic steatohepatitis in young patients. | 2016 | Details |
| A19707 | 26401084 | World J Gastroenterol | Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity. | 2015 | Details |
| A19708 | 26401075 | World J Gastroenterol | Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. | 2015 | Details |
| A19709 | 26400185 | Am J Physiol Regul Integr Comp Physiol | Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. | 2015 | Details |
| A19710 | 26399838 | J Gastroenterol Hepatol | Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation. | 2016 | Details |
| A19711 | 26399788 | FASEB J | GPR119: a promising target for nonalcoholic fatty liver disease. | 2015 | Details |
| A19712 | 26399510 | Lipids | High Sucrose Intake Ameliorates the Accumulation of Hepatic Triacylglycerol Promoted by Restraint Stress in Young Rats. | 2015 | Details |
| A19713 | 26398456 | Eur J Gastroenterol Hepatol | Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus. | 2015 | Details |
| A19714 | 26398208 | Dig Dis | Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic? | 2015 | Details |
| A19715 | 26397391 | Mol Med Rep | Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in mice. | 2015 | Details |
| A19716 | 26397280 | Rev Gastroenterol Peru | [Clinical and biochemical characteristics in patients with histology compatible with steatothepatitis in National Hospital Arzobispo Loayza, Lima, Peru, from 2010 to 2012]. | 2017 | Details |
| A19717 | 26397061 | Mol Med Rep | Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice. | 2015 | Details |
| A19718 | 26396715 | Middle East J Dig Dis | Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010. | 2015 | Details |
| A19719 | 26395746 | Int J Obes (Lond) | A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. | 2015 | Details |
| A19720 | 26395497 | BMJ Open | Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. | 2015 | Details |
| A19721 | 26395315 | Expert Rev Gastroenterol Hepatol | Cholesterol is a significant risk factor for non-alcoholic steatohepatitis. | 2015 | Details |
| A19722 | 26395162 | Sci Rep | Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies. | 2015 | Details |